Top Markets
Coin of the day
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Kedudukan dalam Saham #28220
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Harga Saham
$0.4
Disegerakkan terakhir: 2026-10-02
Modal Pasaran
$27.18M
Perubahan (1 hari)
-14.88%
Perubahan (1 tahun)
8.11%
Negara
US
Perdagangan Cell Source, Inc. (CLCS)

Kategori

Nisbah P/B bagi Cell Source, Inc. (CLCS)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Cell Source, Inc., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Cell Source, Inc. dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
6.5558 -
US
11.2791 -
US
4.0142 -
AU
7.082 -
NL
- -
CH